hepatitis-b

Documents about hepatitis-b

• Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.#28420ClinicalTrials.gov
• B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B#67676ClinicalTrials.gov
• Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine#67679ClinicalTrials.gov
• Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine#123461ClinicalTrials.gov
• Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®#123563ClinicalTrials.gov
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults#343700ClinicalTrials.gov
• Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine#346966ClinicalTrials.gov
• Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines#346974ClinicalTrials.gov
• Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .#346982ClinicalTrials.gov
• Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine#353342ClinicalTrials.gov
• Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder#356544ClinicalTrials.gov
• Risk Assessment of Long-Haul Truck Drivers#356556ClinicalTrials.gov
• Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants#363650ClinicalTrials.gov
• Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc#363657ClinicalTrials.gov
• Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025#366646ClinicalTrials.gov

Related topics